Intracellular Cytokine Production in ANCA-associated Vasculitis: Low Levels of Interleukin-10 in Remission Are Associated with a Higher Relapse Rate in the Long-term Follow-up

Archives of Medical Research

Volumn 40, Issue 4, 2009, Pages 276-284

  Hruskova, Zdenka ^a   Rihova, Zuzana ^a   Mareckova, Helena ^a   Jancova, Eva ^a   Rysava, Romana ^a   Zavada, Jakub ^a   Merta, Miroslav ^a   Löster, Tomas ^b   Tesar, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF ECONOMICS   (Czech Republic)

Author keywords

Anti neutrophil cytoplasmic autoantibodies (ANCA); Interleukin 10; Intracellular cytokines; Relapse; Vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PROGNOSIS; RECURRENCE RISK; RELAPSE; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; VASCULITIS;

EID: 67650073210     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.04.001     Document Type: Article

References (45)

1. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides-proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
2. Jennette J.C., and Falk R.J. Small vessel vasculitis. N Engl J Med 337 (1997) 1512-1523
3. Jennette J.C., Wilkman A.S., and Falk R.J. Diagnostic predictive value of ANCA serology. Kidney Int 53 (1998) 796-798
4. Han W.K., Choi H.K., Roth R.M., McCluskey R.T., and Niles J.L. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63 (2003) 1079-1085
5. Birck R., Schmitt W.H., Kaelsch I.A., and van der Woude F.J. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 47 (2006) 15-23
6. Falk R.J., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318 (1988) 1651-1657
7. Jennette J.C., and Falk R.J. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75 (1990) 2263-2264
8. Rihova Z., Jancova E., Merta M., et al. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Kidney Blood Press Res 28 (2005) 144-152
9. Sanders J.S., Huitma M.G., Kallenberg C.G., and Stegeman C.A. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology 45 (2006) 724-729
10. Slot M.C., Tervaert J.W., Boomsma M.M., and Stegeman C.A. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum 51 (2004) 269-273
11. van Paassen P., Cohen Tervaert J.W., and Heeringa P. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?. Nephron Exp Nephrol 105 (2007) e10-e16
12. Morgan M.D., Harper L., Williams J., and Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 17 (2006) 1224-1234
13. Bosch X., Guilabert A., and Font J. Antineutrophil cytoplasmic antibodies. Lancet 368 (2006) 404-4018
14. Sarraf P., and Sneller M.C. Pathogenesis of Wegener's granulomatosis: current concepts. Expert Rev Mol Med 7 (2005) 1-19
15. Schmitt W.H., Heesen C., Csernok E., Rautman A., and Gross W.L. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 35 (1992) 1088-1096
16. Stegeman C.A., Cohen Tervaert J.W., Huitema M.G., and Kallenberg C.G.M. Serum markers of T-cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 91 (1993) 415-420
17. Popa E.R., Stegeman C.A., Bos N.A., Kallenberg C.G., and Cohen Tervaert J.W. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 103 (1999) 885-894
18. Marinaki S., Kalsch A.I., Grimminger P., et al. Persistent T cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol Dial Transplant 21 (2006) 1825-1832
19. Marinaki S., Neumann I., Kalsch A.I., et al. Abnormalities of CD4+ T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 140 (2005) 181-191
20. Ludviksson B.R., Sneller M.C., Chua K.S., et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 160 (1998) 3602-3609
21. Popa E.R., Franssen C.F., Limburg P.C., Huitema M.G., Kallenberg C.G., and Tervaert J.W. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 46 (2002) 1894-1904
22. Ohlsson S., Wieslander J., and Segelmark M. Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?. Mediators Inflamm 13 (2004) 275-283
23. Sanders J.S., Huitma M.G., Kallenberg C.G., and Stegeman C.A. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 65 (2006) 1484-1489
24. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., and Arend W.P. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33 (1990) 1094-1100
25. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., and Arend W.P. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33 (1990) 1101-1107
26. Flossmann O., Bacon P., de Groot K., et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66 (2007) 283-292
27. Marecková H., Ravdan A., Fucíková T., and Janatková I. Detection of the production of intracellular cytokines by T lymphocytes using flow cytometry-methodologic problems. Epidemiol Mikrobiol Imunol 51 (2002) 111-118
28. Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141 (2005) 201-210
29. Sanders J.S.F., Stegeman C.A., and Kallenberg C.G.M. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res 26 (2003) 215-220
30. Csernok E., Trabandt A., Müller A., et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 42 (1999) 742-750
31. Balding C.E.J., Howie A.J., Drake-Lee A.B., and Savage C.O.S. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol 125 (2001) 332-339
32. Muller A., Trabandt A., Gloeckner-Hofmann K., et al. Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 192 (2000) 113-120
33. Masutani K., Tokumoto M., Nakashima H., et al. Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59 (2003) 395-405
34. Schönermarck U., Csernok E., Trabandt A., Hansen H., and Gross W.L. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 18 (2000) 457-463
35. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 (2006) 17-23
36. Abdulahad W.H., Stegeman C.A., Limburg P.C., and Kallenberg C.G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 58 (2008) 2196-2205
37. Komocsi A., Lamprecht P., Csernok E., et al. Peripheral blood and granuloma CD4(+) CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 160 (2002) 1717-1724
38. Abdulahad W.H., Stegeman C.A., Limburg P.C., and Kallenberg C.G. CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann NY Acad Sci 1107 (2007) 22-31
39. Rarok A.A., Limburg P.C., and Kallenberg C.G. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74 (2003) 3-15
40. Romani L., Mencacci A., Cenci E., et al. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol 158 (1997) 5349-5356
41. Hogan S.L., Falk R.J., Chin H., Cai J., Jennette C.E., Jennette J.C., and Nachman P.H. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143 (2005) 621-631
42. Bártfai Z., Gaede K.I., Russell K.A., Muraközy G., Müller-Quernheim J., and Specks U. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol 109 (2003) 330-337
43. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
44. Zhou Y., Giscombe R., Huang D., and Lefvert A.K. Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene. J Rheumatol 29 (2002) 317-320
45. Huugen D., Cohen Tervaert J.W., and Heeringa P. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations. Clin J Am Soc Nephrol 1 (2006) 1100-1107